FDA approves Pfizer’s new nasal spray treatment for migraines
The U.S. Food and Drug Administration has authorized Pfizer’s most recent drug on the migraine marketplace, Zavzpret (zavegepant) — the to start with and only migraine cure of its sort to be available in nasal spray. The drug has proven in medical trial details to offer swift ache reduction in as fast as 15 minutes for migraine sufferers, with relief lasting up to 48 several hours, Pfizer mentioned. Migraines are one of the most prevalent debilitating health care ailments, said…